ANNMARIE BADAGLIACCA: Open Payments
NPI 1982778916 · MEDFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 59 payments from 23 companies in 2025. Trend: 2023 $774 · 2024 $808 · 2025 $1,399
Food & beverage: $1,399
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $127 |
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $87 |
| Vifor Pharma, Inc. | 3 | $81 |
| Lilly USA, LLC | 4 | $80 |
| ABBVIE INC. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Amgen Inc. | 3 | $69 |
| Grifols USA, LLC | 2 | $66 |
Products named: JARDIANCE, GLASSIA, Zemaira, AIRSUPRA, REXULTI, Prolastin-C Liquid, CAPLYTA, Veozah.
Industry payments across NY — which companies pay providers there.
